STOCK TITAN

Kamada Ltd (KMDA) Financials

KMDA
FY2025 annual
Revenue $180.5M +12.1% YoY
Net Income $20.2M +39.7% YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow $25.5M -46.4% YoY
Market Cap $461.7M as of Oct 6, 2026
Price / Sales 2.6x on $180.5M revenue, FY2025
Price / Earnings 22.9x on $20.2M net income, FY2025
Price / Book 1.7x on $269.1M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the KMDA SEC filings page.

Kamada Ltd (KMDA) reported $180.5M in revenue for fiscal year 2025, up 12.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI KMDA FY2025

Kamada has shifted from losses to profitable growth, while cash conversion moderated against its latest reported earnings.

From FY2023 to FY2025, revenue grew 26.6% while net margin reached 11.2%, indicating that more sales reached the bottom line; the missing operating-profit data prevents isolating whether mix, costs, or scale drove the improvement. Operating cash flow exceeded net income in both FY2024 and FY2025, but the relationship narrowed from roughly 3.3x to 1.3x, so earnings remained cash-supported without converting as generously in the latest year.

At FY2025, total liabilities were $109.6M against $269.1M of equity, leaving a balance sheet financed mainly by equity rather than obligations. The 4.1x current ratio adds short-term flexibility, although it does not mean every current asset is immediately cash.

Inventory stood at $84.9M, or roughly 44.0% of current assets, making working-capital liquidity partly dependent on selling stock rather than solely collecting receivables. That concentration helps explain why a high current ratio should not be read as frictionless cash availability.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Kamada Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
7/8

Kamada Ltd passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.26x

For every $1 of reported earnings, Kamada Ltd generates $1.26 in operating cash flow ($25.5M OCF vs $20.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$44.7M
YoY+14.5%
QoQ-5.0%

Kamada Ltd generated $44.7M in revenue in Q4 2025. This represents an increase of 14.5% from the same quarter a year earlier. Against the prior quarter it is down 5.0%.

Net Income
$3.6M
YoY-6.5%
QoQ-32.7%

Kamada Ltd reported $3.6M in net income in Q4 2025. This represents a decrease of 6.5% from the same quarter a year earlier. Against the prior quarter it is down 32.7%.

EBITDA

Not reported for Q4 2025.

EPS (Diluted)

Not reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt
$75.5M
YoY-3.8%
QoQ+4.8%
5Y CAGR+7.5%

Kamada Ltd held $75.5M in cash against $9.4M in long-term debt as of Q4 2025.

Shares Outstanding
58M
YoY+0.3%
QoQ0.0%

Kamada Ltd had 58M shares outstanding in Q4 2025. This represents an increase of 0.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

Net Margin
8.0%
YoY-1.8pp
QoQ-3.3pp

Kamada Ltd's net profit margin was 8.0% in Q4 2025, showing the share of revenue converted to profit. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.3 percentage points.

Return on Equity
1.3%
YoY-0.1pp
QoQ-0.7pp

Kamada Ltd's ROE was 1.3% in Q4 2025, measuring profit generated per dollar of shareholder equity. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Gross Margin

Not reported for Q4 2025.

Operating Margin

Not reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

KMDA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KMDA quarterly income statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'2510-QQ4'2420-FQ3'246-KQ2'246-KQ1'2410-Q
Revenue$44.7M+14.5%$47.0M+12.6%$44.8M+5.4%$44.0M+16.6%$39.0M-62.7%$41.7M+10.0%$42.5M+13.4%$37.7M+22.9%
Interest Expense$259K+37.0%$221K+32.3%$192K+32.4%$192K+20.8%$189K-89.9%$167K+115.6%$145K+120.0%$159K-100.0%
Income Tax$1.2M+186.9%$1.1M+1175.0%-$1.6M-2676.2%$2.6M+3479.7%-$1.3M-2390.1%$84K+15.1%$63K-32.3%$74K-99.4%
Net Income$3.6M-6.5%$5.3M+37.1%$7.4M+66.7%$4.0M+67.6%$3.8M-24.8%$3.9M+19.9%$4.4M+144.3%$2.4M+230.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

KMDA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KMDA quarterly balance sheet
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'2510-QQ4'2420-FQ3'246-KQ2'246-KQ1'2410-Q
Total Assets$378.7M+1.7%$377.2M+7.4%$368.2M+4.9%$375.1M+9.3%$372.3M+4.9%$351.2M+4.2%$351.0M+11.7%$343.2M+8.3%
Current Assets$193.1M+4.7%$192.7M+17.2%$183.3M+10.1%$188.5M+19.4%$184.3M+8.5%$164.4M+7.3%$166.4M+28.3%$157.8M+20.1%
Cash & Equivalents$75.5M-3.8%$72.0M0.0%$66.0M+16.7%$76.3M+58.2%$78.4M+41.0%$72.0M+36.9%$56.5M+159.5%$48.2M+77.7%
Inventory$84.9M+7.8%$85.4M+19.4%$82.1M+4.3%$78.4M-7.1%$78.8M-10.9%$71.6M-3.0%$78.7M-1.9%$84.3M+5.8%
Goodwill$30.3M0.0%$30.3M0.0%$30.3M0.0%$30.3M0.0%$30.3M0.0%$30.3M$30.3M$30.3M
Total Liabilities$109.6M-2.8%$112.0M+16.7%$108.2M+8.3%$123.1M+33.8%$112.8M+1.7%$95.9M-2.8%$99.9M+100.1%$92.0M+100.1%
Current Liabilities$47.4M-4.0%$47.8M+40.7%$45.8M+11.9%$57.0M+53.5%$49.4M-0.4%$34.0M-8.8%$40.9M-37.9%$37.2M-46.3%
Non-Current Liabilities$62.2M-1.8%$64.1M+3.5%$62.4M+5.9%$66.1M+11.1%$63.4M+3.4%$61.9M+0.9%$59.0M+82046.2%$59.5M+81714.6%
Long-Term Debt$9.4M+0.1%$9.6M-0.2%$9.5M+35.2%$9.3M+28.0%$9.4M+26.8%$9.6M+103.0%$7.1M+42.1%$7.3M+45.8%
Total Equity$269.1M+3.7%$265.2M+3.9%$260.0M+3.5%$252.0M+0.3%$259.5M+6.3%$255.3M+7.1%$251.2M-99.9%$251.2M-99.9%
Retained Earnings-$17.1M+33.7%-$20.6M+30.2%-$25.9M+22.4%-$33.3M+12.0%-$25.7M+36.0%-$29.5M+34.7%-$33.4M+31.1%-$37.8M+24.8%

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.

KMDA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KMDA quarterly cash flow statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'2510-QQ4'2420-FQ3'246-KQ2'246-KQ1'2410-Q
Operating Cash Flow$7.6M-27.2%$10.4M-53.1%$8.0M-42.6%-$513K-150.3%$10.4M+135.8%$22.2M+2311.8%$14.0M+668.0%$1.0M+135.8%
Depreciation & Amortization$3.8M-7.3%$3.8M+16.0%$3.7M+16.0%$3.6M+11.6%$4.1M+27.8%$3.2M+2.0%$3.2M+0.8%$3.2M+3.7%
Investing Cash Flow-$2.8M+5.1%-$3.6M-69.0%-$2.0M+33.1%-$1.5M+45.6%-$2.9M-48.2%-$2.1M-22.8%-$3.0M-187.1%-$2.7M-145.4%
Financing Cash Flow-$1.2M-66.5%-$754K+84.2%-$16.1M-501.9%-$293K+94.9%-$708K-695.0%-$4.8M-115.3%-$2.7M+54.3%-$5.7M-99.2%
Dividends Paid$0$0$11.5MN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

KMDA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

KMDA quarterly financial ratios
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'2510-QQ4'2420-FQ3'246-KQ2'246-KQ1'2410-Q
Net Margin8.0%-1.8pp11.3%+2.0pp16.5%+6.1pp9.0%+2.7pp9.8%+4.9pp9.3%+0.7pp10.4%+5.6pp6.3%+12.2pp
Return on Equity1.3%-0.1pp2.0%+0.5pp2.8%+1.1pp1.6%+0.6pp1.5%-0.6pp1.5%+0.2pp1.8%+1.8pp0.9%+0.9pp
Return on Assets0.9%-0.1pp1.4%+0.3pp2.0%+0.7pp1.1%+0.4pp1.0%-0.4pp1.1%+0.1pp1.3%+0.7pp0.7%+1.3pp
Current Ratio4.07+0.3x4.03-0.8x4.00-0.1x3.30-0.9x3.73+0.3x4.84+0.7x4.07+2.1x4.25+2.3x
Debt-to-Equity0.040.0x0.040.0x0.040.0x0.040.0x0.040.0x0.040.0x0.030.0x0.030.0x
Asset Turnover0.120.0x0.120.0x0.120.0x0.120.0x0.10-0.2x0.120.0x0.120.0x0.110.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Kamada Ltd KMDA FY2025 $180.5M $20.2M 11.2% $461.7M —
Eton Pharmaceutcials, Inc. ETON FY2025 $80.0M -$4.6M -5.8% $1.6B 51/100
Emergent Biosolutions, Inc. EBS FY2025 $742.9M $52.6M 7.1% $324.6M 36/100
Evolus, Inc. EOLS FY2025 $297.2M -$51.6M -17.4% $471.6M 34/100
Canopy Growth Corporation CGC FY2026 N/A -$189.0M N/A $370.3M —
Aquestive Therapeutics, Inc. AQST FY2025 $44.5M -$83.8M N/A $571.1M 35/100

Frequently Asked Questions

What is Kamada Ltd's annual revenue?

Kamada Ltd (KMDA) reported $180.5M in total revenue for fiscal year 2025. This represents a 12.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Kamada Ltd's revenue growing?

Kamada Ltd (KMDA) revenue grew by 12.1% year-over-year, from $161.0M to $180.5M in fiscal year 2025.

Is Kamada Ltd profitable?

Yes, Kamada Ltd (KMDA) reported a net income of $20.2M in fiscal year 2025, with a net profit margin of 11.2%.

As of fiscal year 2025, Kamada Ltd (KMDA) had $75.5M in cash and equivalents against $9.4M in long-term debt.

Kamada Ltd (KMDA) had a net profit margin of 11.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Kamada Ltd (KMDA) has a return on equity of 7.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Kamada Ltd (KMDA) generated $25.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Kamada Ltd (KMDA) had $378.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Kamada Ltd (KMDA) had 58M shares outstanding as of fiscal year 2025.

Kamada Ltd (KMDA) had a current ratio of 4.07 as of fiscal year 2025, which is generally considered healthy.

Kamada Ltd (KMDA) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Kamada Ltd (KMDA) had a return on assets of 5.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Kamada Ltd (KMDA) trades at 22.9x earnings, its market capitalization divided by net income of $20.2M net income, FY2025. The market capitalization is $461.7M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Kamada Ltd (KMDA) trades at 2.6x sales, its market capitalization divided by revenue of $180.5M revenue, FY2025. The market capitalization is $461.7M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Kamada Ltd (KMDA) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Kamada Ltd (KMDA) has an earnings quality ratio of 1.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top